Loading clinical trials...
Loading clinical trials...
The goal of this double-blind, randomised, controlled trial is to determine the effects of LC n-3 PUFAs supplementation on changes in body composition and muscle strength during body weight loss and b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Glasgow
NCT05725967 · Obesity, Obesity, Morbid, and more
NCT04799665 · Metabolic Syndrome, Obesity Associated Disorder
NCT03615534 · Atherogenic Dyslipidemia, Obesity Associated Disorder
NCT05645926 · Obesity Associated Disorder, Myocardial Infarction
NCT05508997 · Obesity Associated Disorder
University of Glasgow, New Lister Building
Glasgow, Scotland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions